GABAPENTIN
GABAPENTIN
Discontinued
DIN Number
02238672
Drug Class
Human
Market Date
N/A
Company
HC
omni laboratories division, warner-lambert canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02238672
AIG Number0125929003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BF01 GABAPENTIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
GABAPENTINActive
Strength: 300 MG / CAP
Monograph: GABAPENTIN